Artikel ; Online: Evaluation of repRNA vaccine for induction and in utero transfer of maternal antibodies in a pregnant rabbit model.
Molecular therapy : the journal of the American Society of Gene Therapy
2023 Band 31, Heft 4, Seite(n) 1046–1058
Abstract: Mother-to-child transmission is a major route for infections in newborns. Vaccination in mothers to leverage the maternal immune system is a promising approach to vertically transfer protective immunity. During infectious disease outbreaks, such as the ... ...
| Abstract | Mother-to-child transmission is a major route for infections in newborns. Vaccination in mothers to leverage the maternal immune system is a promising approach to vertically transfer protective immunity. During infectious disease outbreaks, such as the 2016 Zika virus (ZIKV) outbreak, rapid availability of vaccines can prove critical in reducing widespread disease burden. The recent successes of mRNA vaccines support their evaluation in pregnant animal models to justify their use in neonatal settings. Here we evaluated immunogenicity of self-amplifying replicon (repRNA) vaccines, delivered with our clinical-stage LION nanoparticle formulation, in pregnant rabbits using ZIKV and HIV-1 as model disease targets. We showed that LION/repRNA vaccines induced robust antigen-specific antibody responses in adult pregnant rabbits that passively transferred to newborn kits in utero. Using a matrixed study design, we further elucidate the effect of vaccination in kits on the presence of pre-existing maternal antibodies. Our findings showed that timing of maternal vaccination is critical in maximizing in utero antibody transfer, and subsequent vaccination in newborns maintained elevated antibody levels compared with no vaccination. Overall, our results support further development of the LION/repRNA vaccine platform for maternal and neonatal settings. |
|---|---|
| Mesh-Begriff(e) | Pregnancy ; Animals ; Female ; Rabbits ; Zika Virus ; Zika Virus Infection ; Infectious Disease Transmission, Vertical/prevention & control ; Vaccines ; Antibodies, Viral ; Antibodies, Neutralizing |
| Chemische Substanzen | Vaccines ; Antibodies, Viral ; Antibodies, Neutralizing |
| Sprache | Englisch |
| Erscheinungsdatum | 2023-03-24 |
| Erscheinungsland | United States |
| Dokumenttyp | Journal Article ; Research Support, N.I.H., Extramural |
| ZDB-ID | 2010592-7 |
| ISSN | 1525-0024 ; 1525-0016 |
| ISSN (online) | 1525-0024 |
| ISSN | 1525-0016 |
| DOI | 10.1016/j.ymthe.2023.02.022 |
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
| Zs.A 5640: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.